Cytotoxicity and cell interaction studies of bioadhesive poly(anhydride) nanoparticles for oral antigen/drug delivery

Journal of Biomedical Nanotechnology

Volumn 9, Issue 11, 2013, Pages 1891-1903

  Ojer, Patricia ^a   Neutsch, Lukas ^b   Gabor, Franz ^b   Irache, Juan Manuel ^a   López De Cerain, Adela ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Caco 2; Cytoadhesion; Cytotoxicity; HepG2; Oral; Poly(anhydride) nanoparticles

Indexed keywords

CACO-2; CYTOADHESION; FLUORESCENCE CONFOCAL MICROSCOPY; HEPG2; NEGATIVE SURFACE CHARGES; ORAL; PHARMACEUTICAL APPLICATIONS; POLY(ETHYLENE GLYCOL) 6000;

CELL CULTURE; CELL MEMBRANES; CYTOTOXICITY; DRUG DELIVERY; FUNCTIONAL POLYMERS; POLYETHYLENE GLYCOLS;

NANOPARTICLES;

ADHESIVE AGENT; CYCLODEXTRIN; MACROGOL; NANOPARTICLE; POLYANHYDRIDE;

ARTICLE; CELL ADHESION; CELL INTERACTION; CELL INVASION; CELL PROLIFERATION; CELL STRAIN CACO 2; CELL STRAIN HEPG2; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; SURFACE CHARGE; ZETA POTENTIAL;

ADMINISTRATION, ORAL; ANTIGENS; CACO-2 CELLS; CELL SURVIVAL; DIFFUSION; HEP G2 CELLS; HUMANS; MATERIALS TESTING; NANOCAPSULES; PARTICLE SIZE; POLYANHYDRIDES; SUBCELLULAR FRACTIONS;

EID: 84883691439     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1695     Document Type: Article

References (37)

1. J. Curtis, M. Greenberg, J. Kester, S. Phillips, and G. Krieger, Nanotechnology and nanotoxicology: a primer for clinicians. Toxicol Rev. 25, 245 (2006).
2. M. Kurath and S. Maasen, Toxicology as a nanoscience?-disciplinary identities reconsidered. Part Fibre Toxicol. 3, 6 (2006).
3. A. Nel, T. Xia, L. Madler, and N. Li, Toxic potential of materials at the nanolevel. Science 311, 622 (2006).
4. C. Medina, M. J. Santos-Martinez, A. Radomski, O. I. Corrigan, and M. W. Radomski, Nanoparticles: pharmacological and toxicological significance. Br. J. Pharmacol. 150, 552 (2007).
5. J. Panyam and V. Labhasetwar, Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55, 329 (2003)
6. V. Stone and K. Donaldson, Nanotoxicology: signs of stress. Nat. Nanotechnol. 1, 23 (2006).
7. K. Donaldson, V. Stone, A. Clouter, L. Renwick, and W. MacNee, Ultrafine particles. Occup. Environ. Med. 58, 211 (2001).
8. Y. Pan, S. Neuss, A. Leifert, M. Fischler, F. Wen, U. Simon, G. Schmid, W. Brandau, and W. Jahnen-Dechent, Size-dependent cytotoxicity of gold nanoparticles. Small 3, 1941 (2007).
9. D. Hohr, Y. Steinfartz, R. P. Schins, A. M. Knaapen, G. Martra, B. Fubini, and P. J. Borm, The surface area rather than the surface coating determines the acute inflammatory response after instillation of fine and ultrafine TiO2 in the rat. Int. J. Hyg. Environ. Health 205, 239 (2002).
10. S. E. McNeil, Nanotechnology for the biologist. J. Leukoc. Biol. 78, 585 (2005).
11. R. Duncan and R. Gaspar, Nanomedicine(s) under the microscope. Mol. Pharm. 8, 2101 (2011).
12. M. Agueros, S. Espuelas, I. Esparza, P. Calleja, I. Penuelas, G. Ponchel, and J. M. Irache, Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery. Expert Opin. Drug Deliv. 8, 721 (2011).
13. A. I. Camacho, J. de Souza, S. Sanchez-Gomez, M. Pardo-Ros, J. M. Irache, and C. Gamazo, Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice. Vaccine. 29, 8222 (2011).
14. S. Gomez, C. Gamazo, B. San Roman, A. Grau, S. Espuelas, M. Ferrer, M. L. Sanz, and J. M. Irache, A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne. J. Immunol. Methods 348, 1 (2009).
15. K. Yoncheva, S. Gomez, M. A. Campanero, C. Gamazo, and J. M. Irache, Bioadhesive properties of pegylated nanoparticles. Expert Opin. Drug Deliv. 2, 205 (2005).
16. M. Agueros, L. Ruiz-Gaton, C. Vauthier, K. Bouchemal, S. Espuelas, G. Ponchel, and J. M. Irache, Combined hydroxypropyl-betacyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel. Eur. J. Pharm. Sci. 38, 405 (2009).
17. P. Ojer, H. Salman, R. Da Costa Martins, J. Calvo, A. López de Cerain, C. Gamazo, J. L. Lavandera, and J. M. Irache, Spray-drying of poly(anhydride) nanoparticles for drug/antigen delivery. J. Drug Del. Sci. Tech. 20, 353 (2010).
18. M. Agueros, M. A. Campanero, and J. M. lrache, Simultaneous quantification of different cyclodextrins and Gantrez by HPLC with evaporative light scattering detection. J. Pharm. Biomed. Anal. 39, 495 (2005).
19. V. Zabaleta, M. A. Campanero, and J. M. Irache, An HPLC with evaporative light scattering detection method for the quantification of PEGs and Gantrez in PEGylated nanoparticles. J. Pharm. Biomed. Anal. 44, 1072 (2007).
20. N. Lewinski, V. Colvin, and R. Drezek, Cytotoxicity of nanoparticles. Small 4, 26 (2008).
21. C. I. Vamanu, M. R. Cimpan, P. J. Hol, S. Sornes, S. A. Lie, and N. R. Gjerdet, Induction of cell death by TiO2 nanoparticles: studies on a human monoblastoid cell line. Toxicol In Vitro. 22, 1689 (2008).
22. T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55 (1983).
23. P. Arbos, M. Wirth, M. A. Arangoa, F. Gabor, and J. M. Irache, Gantrez AN as a new polymer for the preparation of ligandnanoparticle conjugates. J. Control Release 83, 321 (2002).
24. J. Haas and C. M. Lehr, Developments in the area of bioadhesive drug delivery systems. Expert Opin. Biol. Ther. 2, 287 (2002).
25. V. Zabaleta, G. Ponchel, H. Salman, M. Agueros, C. Vauthier, and J. M. Irache, Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study. Eur. J. Pharm. Biopharm. 81, 514 (2012).
26. J. Calvo, J. L. Lavandera, M. Agueros, and J. M. Irache, Cyclodextrin/ poly(anhydride) nanoparticles as drug carriers for the oral delivery of atovaquone. Biomed Microdevices (2011).
27. P. Arbos, M. A. Campanero, M. A. Arangoa, and J. M. Irache, Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines. J. Control Release 96, 55 (2004).
28. A. I. Camacho, R. Da Costa Martins, I. Tamayo, J. de Souza, J. J. Lasarte, C. Mansilla, I. Esparza, J. M. Irache, and C. Gamazo, Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators. Vaccine. 29, 7130 (2011).
29. P. Artursson and C. Magnusson, Epithelial transport of drugs in cell culture. II: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells. J. Pharm. Sci. 79, 595 (1990).
30. A. R. Hilgers, R. A. Conradi, and P. S. Burton, Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm. Res. 7, 902 (1990).
31. G. Oberdorster, A. Maynard, K. Donaldson, V. Castranova, J. Fitzpatrick, K. Ausman, J. Carter, B. Karn, W. Kreyling, D. Lai, S. Olin, N. Monteiro-Riviere, D. Warheit, and H. Yang, Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol. 2, 8 (2005).
32. M. D. Peterson, W. M. Bement, and M. S. Mooseker, An in vitro model for the analysis of intestinal brush border assembly. II. Changes in expression and localization of brush border proteins during cell contact-induced brush border assembly in Caco-2BBe cells. J. Cell Sci. 105, 461 (1993).
33. Y. Yuan, C. Liu, J. Qian, J. Wang, and Y. Zhang, Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells. Biomaterials 31, 730 (2010).
34. J. Zou, Q. Chen, X. Jin, S. Tang, K. Chen, T. Zhang, and X. Xiao, Olaquindox induces apoptosis through the mitochondrial pathway in HepG2 cells. Toxicology 285, 104 (2011).
35. K. Knop, R. Hoogenboom, D. Fischer, and U. S. Schubert, Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. Engl. 49, 6288 (2010).
36. M. Wirth, C. Kneuer, C. M. Lehr, and F. Gabor, Lectin-mediated drug delivery: discrimination between cytoadhesion and cytoinvasion and evidence for lysosomal accumulation of wheat germ agglutinin in the Caco-2 model. J. Drug Target. 10, 439 (2002).
37. A. Weissenboeck, E. Bogner, M. Wirth, and F. Gabor, Binding and uptake of wheat germ agglutinin-grafted PLGA-nanospheres by caco-2 monolayers. Pharm. Res. 21, 1917 (2004).